Ligand Pharmaceuticals Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022
Revenue	2,843,093	2,811,806	2,765,202	1,863,153
Revenue Growth (YoY)	7.15%	1.69%	48.41%	-
Cost of Revenue	2,602,740	2,573,106	2,546,646	1,740,099
Gross Profit	240,353	238,700	218,557	123,054
Selling, General & Admin	169,399	171,754	164,767	100,224
Operating Expenses	169,399	171,754	164,767	100,224
Operating Income	70,954	66,946	53,789	22,830
Interest Expense	-53,804	-52,214	-57,756	-17,443
Interest & Investment Income	-	1,109	378.17	11,546
Earnings From Equity Investments	1,813	-878.79	3,264	-
Currency Exchange Gain (Loss)	19.92	19.92	-34.07	-
Other Non Operating Income (Expenses)	3,918	3,389	256.77	7,461
EBT Excluding Unusual Items	22,901	18,372	-101.57	24,395
Gain (Loss) on Sale of Investments	1,800	1,800	-	-
Gain (Loss) on Sale of Assets	274.65	753.48	419.81	-
Pretax Income	24,975	20,926	318.24	24,395
Income Tax Expense	6,851	5,830	33.42	2,560
Earnings From Continuing Operations	18,124	15,096	284.82	21,835
Minority Interest in Earnings	330.19	-850.36	4,810	-1,844
Net Income	18,454	14,246	5,095	19,991
Net Income to Common	18,454	14,246	5,095	19,991
Net Income Growth	342.97%	179.59%	-74.51%	-
Shares Outstanding (Basic)	20	20	20	12
Shares Outstanding (Diluted)	20	20	20	12
Shares Change (YoY)	-0.13%	-	69.07%	-
EPS (Basic)	922.71	712.28	254.76	1690.00
EPS (Diluted)	922.71	712.28	254.76	1690.00
EPS Growth	343.73%	179.59%	-84.93%	-
Free Cash Flow	-393,194	-453,298	62,593	-181,274
Free Cash Flow Per Share	-19659.71	-22664.93	3129.64	-15324.27
Dividend Per Share	1000.000	1000.000	-	-
Gross Margin	8.45%	8.49%	7.90%	6.60%
Operating Margin	2.50%	2.38%	1.94%	1.23%
Profit Margin	0.65%	0.51%	0.18%	1.07%
Free Cash Flow Margin	-13.83%	-16.12%	2.26%	-9.73%
EBITDA	137,029	131,611	109,999	30,476
EBITDA Margin	4.82%	4.68%	3.98%	1.64%
D&A For EBITDA	66,075	64,664	56,210	7,646
EBIT	70,954	66,946	53,789	22,830
EBIT Margin	2.50%	2.38%	1.94%	1.23%
Effective Tax Rate	27.43%	27.86%	10.50%	10.49%
Revenue as Reported	2,843,093	2,811,806	2,765,202	1,863,153
Advertising Expenses	-	10,844	12,250	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.